Herrero-Labrador R

Title : The Proof-of-Concept of MBA121, a Tacrine-Ferulic Acid Hybrid, for Alzheimer's Disease Therapy - Rodriguez-Ruiz_2023_Int.J.Mol.Sci_24_

Author(s) : Rodriguez-Ruiz ER , Herrero-Labrador R , Fernandez-Fernandez AP , Serrano-Masa J , Martinez-Montero JA , Gonzalez-Nieto D , Hana-Vaish M , Benchekroun M , Ismaili L , Marco-Contelles J , Martinez-Murillo R

Ref : Int J Mol Sci , 24 : , 2023

Abstract :

PubMedSearch : Rodriguez-Ruiz_2023_Int.J.Mol.Sci_24_

PubMedID: 37569630

Title : The proof-of-concept of ASS234: Peripherally administered ASS234 enters the central nervous system and reduces pathology in a male mouse model of Alzheimer disease - Serrano_2017_J.Psychiatry.Neurosci_42_59

Author(s) : Serrano MP , Herrero-Labrador R , Futch HS , Serrano J , Romero A , Fernandez AP , Samadi A , Unzeta M , Marco-Contelles J , Martinez-Murillo R

Ref : J Psychiatry Neurosci , 42 :59 , 2017

Abstract :

PubMedSearch : Serrano_2017_J.Psychiatry.Neurosci_42_59

PubMedID: 27636528

Herrero-Labrador R

References (2)

1. The Proof-of-Concept of MBA121, a Tacrine-Ferulic Acid Hybrid, for Alzheimer's Disease Therapy - Rodriguez-Ruiz_2023_Int.J.Mol.Sci_24_

2. The proof-of-concept of ASS234: Peripherally administered ASS234 enters the central nervous system and reduces pathology in a male mouse model of Alzheimer disease - Serrano_2017_J.Psychiatry.Neurosci_42_59